董事会主席唐纬坤增持远大医药5万股 每股作价8.21港元

Core Viewpoint - The chairman of the board, Tang Weikun, has increased his stake in Yuan Da Pharmaceutical (00512) by purchasing 50,000 shares at a price of HKD 8.21 per share, totaling HKD 410,500, which reflects confidence in the company's future prospects [1] Group 1 - The purchase of shares by the chairman indicates a positive outlook on the company's performance [1] - After the acquisition, the chairman's total shareholding increased to 950,000 shares, representing a 0.03% ownership stake in the company [1]